ASMB
ASSEMBLY BIOSCIENCES, INC.
Key Financials
Operating Income
$-12118000
↑ 73.3%
Net Income
$-6122000
↑ 84.8%
Revenue
$72.3M
↑ 153.5%
Total Liabilities
$50.8M
↓ 40.8%
Total Assets
$257.6M
↑ 116.2%
Cash & Equivalents
$58.5M
↑ 52.4%
EPS (Diluted)
$-0.55
↑ 91.8%
Shareholders' Equity
$206.8M
↑ 519.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 3/31/2026 | View on SEC |
| 4 | 3/31/2026 | View on SEC |
| 4 | 3/31/2026 | View on SEC |
| 4 | 3/31/2026 | View on SEC |
| 4 | 3/31/2026 | View on SEC |
| 8-K | 3/30/2026 | View on SEC |
| EFFECT | 3/27/2026 | View on SEC |
| S-3 | 3/19/2026 | View on SEC |
| S-8 | 3/19/2026 | View on SEC |
| 10-K | 3/19/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ASMB |
| Company Name | ASSEMBLY BIOSCIENCES, INC. |
| CIK | 1426800 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (833) 409-4583 |